Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TECOGEN INC. Director's Dealing 2025

Jun 24, 2025

33623_dirs_2025-06-24_efe0b3f1-00fa-4e16-9418-8ebc9a351794.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TECOGEN INC. (TGEN)
CIK: 0001537435
Period of Report: 2025-03-03

Reporting Person: Lafaille Stephen (VP of Business Development)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-03-03 Common Stock P 400 $2.50 Acquired 400 Direct
2025-06-03 Common Stock X 10000 $0.71 Acquired 10400 Direct
2025-06-03 Common Stock S 10000 $4.88 Disposed 400 Direct
2025-06-04 Common Stock X 15000 $0.71 Acquired 15400 Direct
2025-06-04 Common Stock S 15000 $5 Disposed 400 Direct
2025-06-06 Common Stock X 25000 $1.10 Acquired 25400 Direct
2025-06-06 Common Stock S 25000 $5.98 Disposed 400 Direct
2025-06-23 Common Stock X 10000 $1.10 Acquired 10400 Direct
2025-06-23 Common Stock S 10000 $7.25 Disposed 400 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-06-03 Stock Options (Right to Buy) $0.71 X 10000 Disposed 2030-07-09 Common Stock (50000) Direct
2025-06-04 Stock Options (Right to Buy) $0.71 X 15000 Disposed 2030-07-09 Common Stock (40000) Direct
2025-06-06 Stock Options (Right to Buy) $1.10 X 25000 Disposed 2032-01-21 Common Stock (52500) Direct
2025-06-23 Stock Options (Right to Buy) $1.10 X 10000 Disposed 2032-01-21 Common Stock (25000) Direct

Footnotes

F1: Shares acquired pursuant to exercise of Stock Option Agreement dated 7/9/2020

F2: Multiple share sales between $4.75 and $5.25 per share

F3: 10,000 shares sold for $4.90 per share, and 5,000 shares sold for $5.10 per share

F4: Shares acquired pursuant to stock option agreement dated 1/21/2022

F5: Multiple share sales between $5.85 and $6.10

F6: Vests 50% upon achievement of Adjusted EBITDA goal of 2% of revenue in two consecutive quarters, and 50% upon achievement of Adjusted EBITDA goal of 3% of revenue in four consecutive quarters

F7: Vests 50% per year